Novozymes Sues Danisco Over New Enzyme Patent
Danish biopharmaceutical company Novozymes A/S has wasted no time asserting its newest patent covering a variant of the enzyme alpha amylase, accusing rival Danisco A/S of infringing the patent the same...To view the full article, register now.
Already a subscriber? Click here to view full article